Drug intelligence / Profile preview

NaturaLens

Development stage: Preclinical
Lead developer: NaturaLens
Modality: Device-based Delivery → Drug Delivery Systems
Administration: Ophthalmic

Overview

NaturaLens is a bioengineered contact lens developed by LinkoCare Life Sciences, currently in the preclinical stage of development. Designed as a medical device, it is intended to provide vision correction for refractive errors including myopia, hyperopia, and presbyopia, while simultaneously offering therapeutic support for the ocular surface. The lens is engineered to mimic the natural properties of ocular tissues, which may enhance biocompatibility and moisture retention compared to traditional synthetic contact lenses. This dual-action approach aims to address vision correction needs while providing a supportive environment for patients suffering from dry eye and other ocular surface conditions.

Brand names: NaturaLens

Beyond the preview

Go deeper on NaturaLens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NaturaLens.

Explore the full profile